May-04-24 10:27AM
|
|
May-03-24 12:01PM
|
|
May-02-24 07:30AM
|
|
Apr-30-24 11:15AM
|
(Investor's Business Daily) |
Apr-29-24 10:03AM
|
|
09:50AM |
Loading… |
09:50AM
|
|
Apr-26-24 11:27AM
|
|
05:00AM
|
|
01:02AM
|
|
Apr-25-24 04:05PM
|
|
02:15PM
|
|
07:00AM
|
(The Wall Street Journal) |
01:23AM
|
(Thomson Reuters StreetEvents) |
Apr-24-24 06:18PM
|
|
04:19PM
|
(Investor's Business Daily) |
04:01PM |
Loading… |
04:01PM
|
|
02:12PM
|
|
12:57PM
|
|
12:45PM
|
|
12:28PM
|
|
11:53AM
|
|
11:13AM
|
|
11:08AM
|
|
10:39AM
|
|
10:28AM
|
|
10:05AM
|
|
09:39AM
|
(The Wall Street Journal) |
09:34AM
|
|
09:30AM
|
|
09:00AM
|
|
08:39AM |
Loading… |
08:39AM
|
(The Wall Street Journal) |
08:32AM
|
|
07:45AM
|
|
07:15AM
|
|
06:48AM
|
|
06:45AM
|
(Investor's Business Daily) |
06:45AM
|
|
Apr-23-24 12:23AM
|
|
Apr-19-24 09:39AM
|
|
09:15AM
|
|
Apr-17-24 10:01AM
|
|
Apr-12-24 10:00AM
|
|
Apr-11-24 02:15PM
|
(Investor's Business Daily) |
Apr-10-24 06:09PM
|
|
Apr-01-24 05:50PM
|
|
04:02PM
|
|
Mar-31-24 07:30PM
|
|
11:53AM
|
|
Mar-28-24 08:00AM
|
(Investor's Business Daily) |
Mar-27-24 12:18PM
|
|
Mar-26-24 11:21AM
|
|
Mar-25-24 05:50PM
|
|
Mar-22-24 07:05AM
|
|
06:57AM
|
|
Mar-21-24 05:14PM
|
|
09:17AM
|
|
04:39AM
|
|
Mar-18-24 05:50PM
|
|
10:16AM
|
|
Mar-15-24 09:34AM
|
|
Mar-14-24 11:30AM
|
|
Mar-12-24 05:50PM
|
|
Mar-11-24 12:44PM
|
|
09:00AM
|
|
Mar-08-24 04:11PM
|
|
04:07PM
|
|
02:48PM
|
|
02:38PM
|
|
11:44AM
|
(Associated Press Finance) |
10:58AM
|
|
10:52AM
|
(The Wall Street Journal) |
10:20AM
|
|
Mar-07-24 09:31AM
|
|
Mar-06-24 05:45PM
|
|
07:30AM
|
|
Mar-05-24 05:50PM
|
|
08:33AM
|
|
Mar-04-24 04:15PM
|
|
Mar-02-24 04:53AM
|
|
Mar-01-24 01:45PM
|
(Investor's Business Daily) |
Feb-28-24 05:45PM
|
|
Feb-25-24 07:04AM
|
|
Feb-23-24 12:44PM
|
(Investor's Business Daily) |
07:00AM
|
|
06:14AM
|
|
05:56AM
|
|
Feb-20-24 11:21AM
|
|
Feb-19-24 01:46PM
|
|
Feb-15-24 04:13PM
|
|
Feb-14-24 05:11PM
|
|
09:11AM
|
|
06:42AM
|
|
06:37AM
|
|
06:18AM
|
|
01:35AM
|
(Thomson Reuters StreetEvents) |
Feb-13-24 04:34PM
|
(Morningstar Research) -7.39% |
02:45PM
|
|
01:09PM
|
|
12:53PM
|
|
11:44AM
|
|
|
|
|
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Keeney Adam | Head of Corporate Development | May 01 '24 | Option Exercise | 0.00 | 938 | 0 | 938 | May 03 08:00 PM | Singhal Priya | Head of Development | Apr 02 '24 | Sale | 213.09 | 93 | 19,817 | 4,886 | Apr 03 08:24 PM | Murphy Nicole | Head of Pharm Ops and Tech | Apr 01 '24 | Option Exercise | 0.00 | 240 | 0 | 9,751 | Apr 03 08:11 PM | Singhal Priya | Head of Development | Feb 22 '24 | Sale | 221.23 | 262 | 57,962 | 4,886 | Feb 26 07:54 PM | Singhal Priya | Head of Development | Feb 16 '24 | Option Exercise | 0.00 | 1,208 | 0 | 5,429 | Feb 21 09:27 PM | ALEXANDER SUSAN H | EVP Chief Legal Officer | Feb 16 '24 | Option Exercise | 0.00 | 5,037 | 0 | 52,506 | Feb 21 09:39 PM | Gregory Ginger | EVP, Human Resources | Feb 16 '24 | Option Exercise | 0.00 | 4,704 | 0 | 14,341 | Feb 21 09:36 PM | Izzar Rachid | Head of Global Product Strat. | Feb 16 '24 | Option Exercise | 0.00 | 2,017 | 0 | 10,014 | Feb 21 09:33 PM | Kramer Robin | Chief Accounting Officer | Feb 16 '24 | Option Exercise | 0.00 | 1,345 | 0 | 6,354 | Feb 21 09:31 PM | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Feb 16 '24 | Option Exercise | 0.00 | 6,720 | 0 | 20,692 | Feb 21 09:29 PM | Murphy Nicole | Head of Pharm Ops and Tech | Feb 16 '24 | Option Exercise | 0.00 | 1,260 | 0 | 9,624 | Feb 21 09:28 PM | Singhal Priya | Head of Development | Feb 16 '24 | Sale | 221.49 | 108 | 23,921 | 5,148 | Feb 21 09:27 PM | Rowinsky Eric K | Director | Feb 15 '24 | Buy | 222.54 | 455 | 101,256 | 20,629 | Feb 20 09:13 PM | Singhal Priya | Head of Development | Feb 12 '24 | Sale | 239.45 | 419 | 100,330 | 4,516 | Feb 13 06:06 PM | Singhal Priya | Head of Development | Feb 09 '24 | Option Exercise | 0.00 | 1,212 | 0 | 5,309 | Feb 13 06:06 PM | Murphy Nicole | Head of Pharm Ops and Tech | Feb 09 '24 | Option Exercise | 0.00 | 2,272 | 0 | 9,529 | Feb 13 06:04 PM | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Feb 09 '24 | Option Exercise | 0.00 | 3,257 | 0 | 17,555 | Feb 13 06:03 PM | Kramer Robin | Chief Accounting Officer | Feb 09 '24 | Option Exercise | 0.00 | 833 | 0 | 5,523 | Feb 13 06:01 PM | Gregory Ginger | EVP, Human Resources | Feb 09 '24 | Option Exercise | 0.00 | 2,158 | 0 | 11,778 | Feb 13 06:14 PM | ALEXANDER SUSAN H | EVP Chief Legal Officer | Feb 09 '24 | Option Exercise | 0.00 | 2,575 | 0 | 50,021 | Feb 13 05:56 PM | Izzar Rachid | Head of Global Product Strat. | Feb 09 '24 | Option Exercise | 0.00 | 1,515 | 0 | 9,081 | Feb 13 06:00 PM | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Feb 08 '24 | Option Exercise | 0.00 | 2,335 | 0 | 15,063 | Feb 09 08:03 PM | Murphy Nicole | Head of Pharm Ops and Tech | Feb 08 '24 | Option Exercise | 0.00 | 2,101 | 0 | 7,895 | Feb 09 08:01 PM | Kramer Robin | Chief Accounting Officer | Feb 08 '24 | Option Exercise | 0.00 | 788 | 0 | 4,943 | Feb 09 08:06 PM | Gregory Ginger | EVP, Human Resources | Feb 08 '24 | Option Exercise | 0.00 | 1,635 | 0 | 10,118 | Feb 09 08:14 PM | Izzar Rachid | Head of Global Product Strat. | Feb 08 '24 | Option Exercise | 0.00 | 2,043 | 0 | 8,187 | Feb 09 08:11 PM | ALEXANDER SUSAN H | EVP Chief Legal Officer | Feb 08 '24 | Option Exercise | 0.00 | 2,190 | 0 | 48,101 | Feb 09 08:16 PM | Singhal Priya | Head of Development | Feb 02 '24 | Sale | 245.93 | 634 | 155,920 | 4,097 | Feb 05 06:38 PM | Singhal Priya | Head of Development | Feb 01 '24 | Option Exercise | 0.00 | 1,828 | 0 | 5,292 | Feb 05 06:38 PM | Singhal Priya | Head of Development | Dec 11 '23 | Sale | 248.00 | 110 | 27,280 | 3,464 | Dec 12 05:06 PM | Kramer Robin | Chief Accounting Officer | Dec 08 '23 | Option Exercise | 0.00 | 351 | 0 | 4,325 | Dec 12 05:02 PM | Singhal Priya | Head of Development | Dec 08 '23 | Option Exercise | 0.00 | 426 | 0 | 3,780 | Dec 12 05:06 PM | BIOGEN INC. | 10% Owner | Sep 26 '23 | Sale | 0.50 | 6,000,000 | 3,000,000 | 17,652,466 | Sep 28 05:30 PM | Singhal Priya | Head of Development | Sep 05 '23 | Sale | 269.43 | 431 | 116,124 | 3,354 | Sep 06 06:06 PM | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sep 01 '23 | Option Exercise | 0.00 | 5,285 | 0 | 14,060 | Sep 06 06:08 PM | Singhal Priya | Head of Development | Sep 01 '23 | Option Exercise | 0.00 | 1,668 | 0 | 4,592 | Sep 06 06:06 PM | Singhal Priya | Head of Development | Jul 03 '23 | Sale | 282.87 | 81 | 22,912 | 2,924 | Jul 05 05:33 PM | Singhal Priya | Head of Development | Jun 30 '23 | Option Exercise | 0.00 | 315 | 0 | 3,158 | Jul 05 05:33 PM | Izzar Rachid | Head of Global Product Strat. | Jun 30 '23 | Option Exercise | 0.00 | 504 | 0 | 6,388 | Jul 05 05:37 PM | Kramer Robin | Chief Accounting Officer | Jun 30 '23 | Option Exercise | 0.00 | 252 | 0 | 4,096 | Jul 05 05:35 PM |
|